LFCR
Price
$7.49
Change
-$0.11 (-1.45%)
Updated
Nov 19 closing price
Capitalization
281M
42 days until earnings call
Intraday BUY SELL Signals
TKNO
Price
$4.42
Change
+$0.01 (+0.23%)
Updated
Nov 19 closing price
Capitalization
236.6M
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LFCR vs TKNO

Header iconLFCR vs TKNO Comparison
Open Charts LFCR vs TKNOBanner chart's image
Lifecore Biomedical
Price$7.49
Change-$0.11 (-1.45%)
Volume$120.58K
Capitalization281M
Alpha Teknova
Price$4.42
Change+$0.01 (+0.23%)
Volume$128.57K
Capitalization236.6M
LFCR vs TKNO Comparison Chart in %
LFCR
Daily Signal:
Gain/Loss:
TKNO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LFCR vs. TKNO commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and TKNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (LFCR: $7.50 vs. TKNO: $4.42)
Brand notoriety: LFCR and TKNO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 65% vs. TKNO: 47%
Market capitalization -- LFCR: $281M vs. TKNO: $236.6M
LFCR [@Pharmaceuticals: Generic] is valued at $281M. TKNO’s [@Pharmaceuticals: Generic] market capitalization is $236.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileTKNO’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • TKNO’s FA Score: 0 green, 5 red.
According to our system of comparison, LFCR is a better buy in the long-term than TKNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 6 TA indicator(s) are bullish while TKNO’s TA Score has 3 bullish TA indicator(s).

  • LFCR’s TA Score: 6 bullish, 4 bearish.
  • TKNO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than TKNO.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -8.76% price change this week, while TKNO (@Pharmaceuticals: Generic) price change was -0.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.42%. For the same industry, the average monthly price growth was -7.04%, and the average quarterly price growth was +26.76%.

Reported Earning Dates

LFCR is expected to report earnings on Jan 01, 2026.

TKNO is expected to report earnings on Mar 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.42% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($281M) has a higher market cap than TKNO($237M). LFCR YTD gains are higher at: 0.942 vs. TKNO (-47.066). LFCR has higher annual earnings (EBITDA): -8.81M vs. TKNO (-14.44M). TKNO has more cash in the bank: 24M vs. LFCR (8.27M). TKNO has less debt than LFCR: TKNO (29M) vs LFCR (131M). LFCR has higher revenues than TKNO: LFCR (129M) vs TKNO (38.9M).
LFCRTKNOLFCR / TKNO
Capitalization281M237M119%
EBITDA-8.81M-14.44M61%
Gain YTD0.942-47.066-2%
P/E Ratio51.23N/A-
Revenue129M38.9M332%
Total Cash8.27M24M34%
Total Debt131M29M452%
FUNDAMENTALS RATINGS
LFCR: Fundamental Ratings
LFCR
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LFCRTKNO
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signal:
Gain/Loss:
TKNO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPUSF0.05N/A
+2.82%
ALSET AI VENTURES INC
ANSNF0.05N/A
N/A
Anson Resources
KIERF2.75N/A
N/A
Kier Group Plc
OPHLF11.08N/A
N/A
Ono Pharmaceutical Co., Ltd.
HLNCF4.63-0.15
-3.14%
HALEON PLC

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.32%
NBIX - LFCR
36%
Loosely correlated
-0.41%
AMRX - LFCR
32%
Poorly correlated
-0.43%
SHPH - LFCR
31%
Poorly correlated
-7.58%
ZTS - LFCR
30%
Poorly correlated
-0.90%
TKNO - LFCR
29%
Poorly correlated
+0.23%
More

TKNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TKNO has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TKNO jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKNO
1D Price
Change %
TKNO100%
+0.23%
AMRX - TKNO
34%
Loosely correlated
-0.43%
HROW - TKNO
33%
Loosely correlated
-0.30%
VTRS - TKNO
30%
Poorly correlated
-2.43%
ALKS - TKNO
30%
Poorly correlated
-1.91%
NBIX - TKNO
28%
Poorly correlated
-0.41%
More